Clearstead Advisors, LLC Embecta Corp. Transaction History
Clearstead Advisors, LLC
- $6.44 Billion
- Q4 2024
A detailed history of Clearstead Advisors, LLC transactions in Embecta Corp. stock. As of the latest transaction made, Clearstead Advisors, LLC holds 28 shares of EMBC stock, worth $415. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28
Previous 39
28.21%
Holding current value
$415
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding EMBC
# of Institutions
405Shares Held
53.6MCall Options Held
172KPut Options Held
22.4K-
Black Rock Inc. New York, NY9.19MShares$137 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.03MShares$104 Million0.0% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY3.27MShares$48.6 Million1.68% of portfolio
-
American Century Companies Inc Kansas City, MO3.26MShares$48.4 Million0.04% of portfolio
-
River Road Asset Management, LLC3.25MShares$48.2 Million0.95% of portfolio
About Embecta Corp.
- Ticker EMBC
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 57,836,500
- Market Cap $859M
- Description
- Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...